Status:
COMPLETED
Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
societe SkillCell - 97198 Jarry
CNRS Alcediag UMR9005 - societe Sys2Diag - 34184 Montpellier
Conditions:
SARS-CoV-2
Eligibility:
All Genders
18-90 years
Brief Summary
Coronavirus disease 2019 or COVID-19 is a highly contagious infectious disease. Symptoms of the disease are non-specific (fever, cough, dyspnea and fatigue), common with many seasonal viruses, which c...
Detailed Description
Study taking place at the Montpellier University Hospital, comparing a salivary sample group with active infection (participants) for SARS-COV2 with a salavary sample tested negative (cured, convalesc...
Eligibility Criteria
Inclusion
- \- Control subjects (COV2- group): Participants ( Healthcare staff, patients and DRIVE participants) negative for SARS-CoV-2
- \- Infected subjects (COV2 + group): Patients diagnosed positive for SARS-CoV-2 hospital staff known to be positive and coming to do a control PCR DRIVE participants.
Exclusion
- Eligibility Criteria:
- Inclusion Criteria:
- \- Control subjects (COV2- group): Healthcare staff presumed and diagnosed negative for SARS-CoV-2
- \- Infected subjects (COV2 + group): Patients diagnosed positive for SARS-CoV-2 hospital staff known to be positive and coming to do a control PCR
Key Trial Info
Start Date :
April 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 7 2020
Estimated Enrollment :
627 Patients enrolled
Trial Details
Trial ID
NCT04337424
Start Date
April 13 2020
End Date
October 7 2020
Last Update
November 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCH Montpellier
Montpellier, France, 34295